#CVSHealth, #Aetna, #LarryMerlo, #Johnson&Johnson, #SwissbiotechIdorsia, #hypertension, #aprocitentan
Toronto, Dec 4 (Canadian-Media): CVS Health's decision to acquire Aetna for $69 billion is reported to improve access and reduce healthcare costs for consumers, media reports said.
CVS Health -- largest pharmacy health care provider in the U.S -- is an innovation company with reportedly aims to help people on their path to better health with integrated offerings across the spectrum of pharmacy care under the leadership of .Larry Merlo, President and Chief Executive Officer.
Under Merlo’s leadership, the company is reported to be delivering breakthrough products and services that enable people, usinesses and communities to manage health in more affordable, effective ways.
CVS Health tweeted on @CVSHealth: "CVS Health and Aetna provide greater integration of care, empowering doctors, other health professionals, and patients to make more informed decisions. @AetnaNews."
CEO Merlo's tweet on @CVSHealth said: The traditional health care system lacks the key elements of convenience and coordination that help to engage consumers in their health. That’s what the combination of CVS Health and Aetna will deliver.@AetnaNews.
Johnson & Johnson -- an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company -- will reportedly pay Swiss biotech Idorsia up to $230 million for commercial rights for its experimental hypertension drug aprocitentan.
Johnson & Johnson HQ Bldg, New Jersey: Wikipedia
The hypertension drug aprocitentan is set to enter a Phase-III trial after promising Phase-II results.
In 2010, Barack Obama, president of United States of America and Congress signed Obamacare into law because they wanted to make sure all Americans were able to get health insurance. More important, they wanted to lower the cost of health care. It was reported that would reduce the growing cost of Medicare and Medicaid. Those two programs threaten to take over the entire federal budget.
Within its tax-reform bill, Senate Republicans, according to official reports, repealed Obamacare's individual mandate. Insurance premiums reportedly will likely rise as a result, according to policy experts.
Barack Obama: Facebook
Akili's is reported to have planned to file its experimental digital medicine AKL-T01 incorporating the use of a video game for FDA approval in early 2018 it after showed improved attention performance among children and adolescents with ADHD, according to results from a clinical trial.
When Sanofi's Dengvaxia administered to more than 730,000 children reported that it could worsen the disease, the Philippines suspended its dengue immunization program
(Reporting by Asha Bajaj)